MiR-181a and inflammation: MiRNA homeostasis response to inflammatory stimuli in vivo

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 647-652

  Xie, Weidong ^a   Li, Zhongxin ^b   Li, Mengnan ^a   Xu, Naihan ^a   Zhang, Yaou ^a  

^a TSINGHUA UNIVERSITY   (China)

^b Shenzhen TCM Hospital   (China)

Author keywords

Inflammation; MiR 181a; Toll like receptor 4

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 181A; SMALL INTERFERING RNA; STREPTOZOCIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATIONAL STUDY; HOMEOSTASIS; HUMAN; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; HOMEOSTASIS; HUMANS; INFLAMMATION; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 84872302460     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.097     Document Type: Article

References (19)

1. Ariel A., Timor O. Hanging in the balance. endogenous anti-inflammatory mechanisms in tissue repair and fibrosis. J. Pathol. 2012, 10.1002/path.4108.
2. Liu G., Friggeri A., Yang Y., Park Y.J., Tsuruta Y., Abraham E. MiR-147, a microRNA that is induced upon toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc. Natl. Acad. Sci. USA 2009, 106:15819-15824.
3. Iyer A., Zurolo E., Prabowo A., Fluiter K., Spliet W.G., van Rijen P.C., Gorter J.A., Aronica E. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One 2012, 7:e44789. 10.1371/journal.pone.0044789.
4. Case S.R., Martin R.J., Jiang D., Minor M.N., Chu H.W. MicroRNA-21 inhibits toll-like receptor 2 agonist-induced lung inflammation in mice. Exp. Lung Res. 2011, 37:500-508. 10.3109/01902148.2011.596895.
5. Primo M.N., Bak R.O., Schibler B., Mikkelsen J.G. Regulation of pro-inflammatory cytokines TNFα and IL24 by microRNA-203 in primary keratinocytes. Cytokine 2012, 60:741-748.
6. Sun X., Icli B., Wara A.K., Belkin N., He S., Kobzik L., Hunninghake G.M., Vera M.P., MICU Registry, Blackwell T.S., Baron R.M., Feinberg M.W. MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J. Clin. Invest. 2012, 122:197319-197390. 10.1172/JCI61495.
7. Wu C., Gong Y., Yuan J., Zhang W., Zhao G., Li H., Sun A., Hu K., Zou Y., Ge J. MicroRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos. J. Lipid Res. 2012, 53:2355-2363. 10.1194/jlr.M028878.
8. Zhao J., Gong A.Y., Zhou R., Liu J., Eischeid A.N., Chen X.M. Downregulation of PCAF by miR-181a/b provides feedback regulation to TNF-α-induced transcription of proinflammatory genes in liver epithelial cells. J. Immunol. 2012, 188:1266-1274.
9. Gantier M.P., Stunden H.J., McCoy C.E., Behlke M.A., Wang D., Kaparakis-Liaskos M., Sarvestani S.T., Yang Y.H., Xu D., Corr S.C., Morand E.F., Williams B.R. A miR-19 regulon that controls NF-κB signaling. Nucleic Acids Res. 2012, 40:8048-8058.
10. Kim S.W., Ramasamy K., Bouamar H., Lin A.P., Jiang D., Aguiar R.C. MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc. Natl. Acad. Sci. USA 2012, 109:7865-7870.
11. Zhou R., Li X., Hu G., Gong A.Y., Drescher K.M., Chen X.M. miR-16 targets transcriptional corepressor SMRT and modulates NF-kappaB-regulated transactivation of interleukin-8 gene. PLoS One 2012, 7:e30772.
12. Lu Z., Li Y., Takwi A., Li B., Zhang J., Conklin D.J., Young K.H., Martin R., Li Y. MiR-301a as an NF-κB activator in pancreatic cancer cells. EMBO J. 2011, 30:57-67.
13. Xie W., Zhao Y., Gu D., Du L., Cai G., Zhang Y. Scorpion in combination with gypsum: novel antidiabetic activities in streptozotocin-induced diabetic mice by up-regulating pancreatic PPARγ and PDX-1 expressions. Evid. Based Complement. Alternat. Med. 2011, 2011:683561.
14. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M.J., Oikawa M., Qureshi N., Monks B., Finberg R.W., Ingalls R.R., Golenbock D.T. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 2000, 105:497-504.
15. Joussen A.M., Poulaki V., Le M.L., Koizumi K., Esser C., Janicki H., Schraermeyer U., Kociok N., Fauser S., Kirchhof B., Kern T.S., Adamis A.P. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004, 18:1450-1452.
16. Xie W., Du L. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes. Metab. 2011, 13:289-301. 10.1111/j.1463-1326.2010.01336.x.
17. Dasu M.R., Devaraj S., Park S., Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010, 33:861-868.
18. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 1995, 270:12953-12956.
19. Ji Y., Liu J., Wang Z., Li Z. PPARγ agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4/TRIF/IRF3/IP-10 signaling pathway. Cytokine 2011, 55:409-419.